Even with its shortcomings, the fact that the coverage is being rolled out being a trial is really a constructive factor, reckons Michel Kazatchkine, a member of the Global Commission on Drug Policy. The strongest solution to influence naysayers is thru providing chilly, tricky, irrefutable proof, h